2m 2m 2m 2m 2m 2m 2m
BioCorRx (BICX)
OTC
$0.38+$0.05 (+14.39%)
Price as of Jun 02, 2026- $10.2MMarket Cap
- 4.86%1-Year Change
- Medical Care FacilitiesIndustry
BioCorRx (BICX)
$0.38+$0.05 (+14.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 797,244 +10,301.10% | 7,665 -91.40% | 89,160 -58.31% | 213,841 +342.99% | |
Cost of Revenue | N/A N/A | 1,667 -95.37% | 35,986 +89.94% | 18,946 +222.16% | |
Gross Profit | 797,244 +13,191.83% | 5,998 -88.72% | 53,174 -72.72% | 194,895 +359.76% | |
Sales and Marketing Expense | 3.8M +5.03% | 3.6M +25.65% | 2.9M -15.68% | 3.4M +698.67% | |
Research and Development Expense | -1.8M +19.29% | -1.5M +66.42% | -891,063 -38.95% | -1.5M -9.12% | |
Depreciation and Amortization Expense | 44,003 +32.76% | 33,145 +23.64% | 26,808 -2.34% | 27,450 -57.33% | |
Total Operating Expenses | 5.6M +9.72% | 5.1M +32.32% | 3.9M -21.07% | 4.9M -11.63% | |
Operating Profit | -4.8M -5.68% | -5.1M +35.24% | -3.8M -19.37% | -4.7M -14.74% | |
Interest Income | 223,037 +72.52% | 129,282 +2,350.84% | 5,275 N/A | N/A N/A | |
Interest Expense | 0 +100.00% | -776,780 +300.32% | -194,041 +28.53% | -150,969 -73.31% | |
Interest Income and Expense and Net | 223,037 +134.45% | -647,498 +243.02% | -188,766 +25.04% | -150,969 -73.31% | |
Total Nonoperating Income and Expense | 1.3M +1,576.48% | -89,597 -617.72% | 17,306 -94.61% | 321,163 +7.24% | |
Income before Taxes | -3.5M -32.68% | -5.2M +38.23% | -3.8M -13.85% | -4.4M -16.00% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | 0 N/A | 0 -100.00% | |
Net Income | -3.4M -34.00% | -5.2M +38.23% | -3.8M -13.85% | -4.4M -16.00% | |
Net Income from Continuing Operations Applicable to Common | -3.5M -31.28% | -5.1M +35.42% | -3.8M -13.85% | -4.4M -16.00% | |
Basic EPS and Net Income | N/A N/A | 1.75 0.00% | 1.75 -12.50% | 2.00 +346.91% | |
Diluted EPS and Net Income | -0.19 -110.86% | 1.75 0.00% | 1.75 -12.50% | 2.00 +346.91% | |
Basic Weighted Average Shares | 18.5M +76.66% | 10.5M +25.41% | 8.3M +15.92% | 7.2M +10.90% | |
Diluted Weighted Average Shares | 18.5M +76.66% | 10.5M +25.41% | 8.3M +476.28% | 1.4M -77.69% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 139,360 +58.30% | 88,033 +34.97% | 65,222 -4.94% | 68,615 -20.06% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 139,360 +58.30% | 88,033 +34.97% | 65,222 -4.94% | 68,615 -20.06% | |
Total Current Assets | 814,468 +590.25% | 117,996 -36.94% | 187,119 -40.96% | 316,910 +38.80% | |
Accumulated Depreciation | 190,489 +8.49% | 175,574 +22.26% | 143,608 +21.72% | 117,979 +28.65% | |
Property and Plant and Equipment and Net | 4,062 -78.60% | 18,977 -62.75% | 50,943 -33.47% | 76,572 -25.54% | |
Total Long-Term Assets | 1.2M +2,249.26% | 49,784 -7.03% | 53,547 -47.86% | 102,706 -1.13% | |
Total Assets | 2.1M +456.36% | 385,941 -0.76% | 388,887 -49.27% | 766,594 -6.51% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 0 -100.00% | 1.3M +121.39% | 606,750 -52.90% | 1.3M -66.79% | |
Total Current Liabilities | 8.3M +1.20% | 8.2M +27.62% | 6.4M +19.90% | 5.4M +22.28% | |
Total Long-Term Debt | 4.4M -6.44% | 4.7M -2.24% | 4.8M N/A | 0 -100.00% | |
Total Long-Term Liabilities | 115,745 -27.26% | 159,127 +132.47% | 68,450 -63.07% | 185,373 -47.48% | |
Total Liabilities | 13.7M +7.32% | 12.7M +23.21% | 10.3M +15.31% | 9.0M +15.25% | |
Retained Earnings | -86.6M +4.13% | -83.2M +6.54% | -78.1M +5.07% | -74.3M +6.24% | |
Total Stockholders Equity | -11.2M -7.40% | -12.1M +23.38% | -9.8M +19.78% | -8.2M +19.84% | |
Total Shares Outstanding | 24.5M +84.14% | 13.3M +53.32% | 8.7M +12.38% | 7.7M +15.22% | |
Cash Flow | |||||
Cash from Operating Activities | -2.3M +109.65% | -1.1M -40.85% | -1.9M -9.23% | -2.0M -42.28% | |
Capital Expenditures | N/A N/A | N/A N/A | N/A N/A | 0 -100.00% | |
Cash from Investing Activities | N/A N/A | N/A N/A | N/A N/A | 0 +100.00% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 2.3M +109.96% | 1.1M -39.51% | 1.8M -8.63% | 2.0M -34.30% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | 78.25% +31.21% | 59.64% -34.56% | 91.14% +3.78% | |
Operating Margin | -606.04% -99.09% | -66,829.81% +1,473.09% | -4,248.31% +93.37% | -2,196.96% -80.75% | |
Return on Assets | -271.61% -79.81% | -1,345.36% +106.14% | -652.63% +18.29% | -551.74% +40.14% | |
Return on Equity | 29.47% -37.95% | 47.50% +13.55% | 41.84% -28.10% | 58.18% -38.29% | |
Revenue Growth | 10,301.10% +11,369.96% | -91.40% +56.77% | -58.31% -117.00% | 342.99% +665.68% | |
Current Ratio | 0.10 +581.25% | 0.01 -50.52% | 0.03 -50.76% | 0.06 +13.44% | |
Cash Ratio | 0.02 +57.01% | 0.01 +5.94% | 0.01 -21.09% | 0.01 -34.69% | |
Debt-to-Equity Ratio | -0.39 -21.56% | -0.50 -9.45% | -0.55 +248.19% | -0.16 -87.45% | |
Debt-to-Assets Ratio | 2.03 -86.95% | 15.55 +12.57% | 13.82 +722.23% | 1.68 -83.92% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow